Sotrovimab
Sotrovimab is a human immunoglobulin G IgG it has the potential for placental transfer from the mother to the developing foetus. Sotrovimab is a member of the miscellaneous antivirals drug class and is commonly used for COVID-19. Pin On Daily Mail News Vir Biotechnology Inc. . Sotrovimab is designed to attach to the spike protein of SARS-CoV-2. Sotrovimab is an experimental medicine being studied for use in treating conditions caused by coronavirus. Listing a study does not mean it has been evaluated by the US. Information about Sotrovimab sotrovimab authorized by Health Canada as a Treatment for COVID-19. Sotrovimab is an engineered human IgG1 mAb that binds to a highly conserved epitope on the spike protein receptor binding domainof SARS-CoV-2. Sotrovimab sold under the brand name Xevudy is a human neutralizing monoclonal antibody with activity against severe acute respiratory syndrome coronavirus 2 known as SARS-CoV-2. The...